UGC Chairman Professor Dr Mamun Ahmed said biotechnology curricula are still overly theoretical and not aligned with industry needs.

Nektar Therapeutics (NASDAQ:NKTR) presented 52-week top-line results from a 16-week blinded treatment extension of its Phase ...

Investor's Business Daily has refined its system for grouping stocks to help investors easily see where money is flowing in ...

Before looking at detailed valuation models, it helps to ask a simple question: is Perrigo's current share price of US$11.82 offering you real value or just reflecting recent sentiment swings? Over ...

Scientists believe the Yedoma formation — an ice-rich, organic-laden permafrost formed during the Ice Age — helped sustain ...

This appointment follows recent additions to the company’s Board of Directors, part of a broader effort to strengthen ...

A South African biotechnology collaboration has commercialised a key protein used to produce lab-grown meat. The development ...

Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI ...

Healthcare is not always the most exciting sector to own, and the companies in it grind it out, quarter after quarter, raise ...

Artificial Intelligence (AI) has arguably become the most consequential technological advancement of our era, percolating not ...

The Enforcement Directorate on Saturday conducted raids at multiple locations in poll-bound West Bengal as part of its ...

So, Medtronic is shaking things up, especially with their diabetes division. They’re planning to split it off into its own ...